Cresco Labs Inc
(CRLBF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 217,787 | 215,483 | 209,975 | 178,437 | 162,317 |
| Cost of Goods | 107,765 | 107,162 | 108,994 | 91,414 | 87,835 |
| Gross Profit | 110,022 | 108,321 | 100,981 | 87,023 | 151,721 |
| Operating Expenses | 95,230 | 372,501 | 87,103 | 71,199 | 74,988 |
| Operating Income | 15,557 | -264,018 | 14,872 | 16,238 | 329 |
| Interest Expense | 14,851 | 13,577 | 11,481 | 11,302 | 7,939 |
| Other Income | 10,911 | 1,735 | 12,725 | -13,536 | -19,396 |
| Pre-tax Income | 11,617 | -275,860 | 16,116 | -8,600 | -27,006 |
| Income Tax | 23,528 | -12,408 | 13,463 | 15,524 | 14,181 |
| Net Income Continuous | -11,911 | -263,452 | 2,653 | -24,124 | -48,180 |
| Minority Interests | 2,821 | 7,193 | 7,480 | 5,269 | 13,449 |
| Net Income | $-14,732 | $-270,645 | $-4,827 | $-29,393 | $-48,180 |
| EPS Basic Total Ops | -0.08 | -1.00 | -0.02 | -0.12 | -0.23 |
| EPS Basic Continuous Ops | -0.07 | -0.97 | 0.01 | -0.10 | -0.23 |
| EPS Diluted Total Ops | -0.08 | -1.00 | -0.02 | -0.12 | -0.23 |
| EPS Diluted Continuous Ops | -0.07 | -0.97 | 0.01 | -0.10 | -0.23 |
| EBITDA(a) | $25,045 | $-252,028 | $26,347 | $28,234 | $13,941 |